Jason C. Mixdorf

中国药科大学

H指数:11

被引数:546

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of Bifunctional, PSMA-Targeted Triazamacrocycle-Picolinates Compatible with the 18F/44Sc/177Lu Isotope Triad

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2025-12-010

PRE

Production of 77Br using the GE PETtrace Solid Target Platform

使用GE PETtrace固体靶平台生产77Br

Nuclear Medicine and Biology

IF3

2025-11-100

PRE

The characterization of variable new antigen receptors targeting FAP isolated from a novel immunized library

靶向FAP的变体新抗原受体从一种新型免疫化文库中的分离与表征

Communications Biology

IF5.1

2025-08-130

OAAI

Enhanced tumor retention and therapeutic potency in radionuclide therapy using GSH-induced self-assembling peptides

使用GSH诱导的自组装肽增强放射性核素治疗中的肿瘤滞留和治疗效力

Journal of Controlled Release

IF11.5

2025-08-070

PRE

Solid phase extraction chromatography-based radiochemical isolation of cyclotron-produced 51Mn from enriched 54Fe targets

NUCLEAR MEDICINE AND BIOLOGY

IF3

2025-03-010

PRE

Development and Preclinical Evaluation of [64Cu]Cu-NOTA-ABDB6: A CD70 and Albumin Dual-Binding Tracer with Improved Pharmacokinetics

[64Cu]Cu-NOTA-ABDB6的开发与临床前评估：一种具有改善药代动力学的CD70和清蛋白双靶向示踪剂

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2025-02-270

PRE

Controlling the Redox Chemistry of Cobalt Radiopharmaceuticals

控制钴放射性药物的氧化还原化学

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2024-11-051

PRE

Off-Label Use of the Siderophore Enterobactin Enables Targeted Imaging of Cancer with Radioactive Ti(IV)

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2024-03-252

PRE

Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer

BIOCONJUGATE CHEMISTRY

IF3.9

2024-03-123

PRE

Radiolabeling Diaminosarcophagine with Cyclotron-Produced Cobalt-55 and [55Co]Co-NT-Sarcage as a Proof of Concept in a Murine Xenograft Model

BIOCONJUGATE CHEMISTRY

IF3.9

2024-02-274

PRE

Charting the coordinative landscape of the 18F-Sc/44Sc/177Lu triad with the tri-aza-cyclononane (tacn) scaffold

CHEMICAL SCIENCE

IF7.4

2024-01-010

OAAI

De Novo Approaches to the Solid-Phase Separation of Titanium(IV) and Scandium(III): Translating Speciation Data to Selective On-Bead Chelation toward Applications in Nuclear Medicine

INORGANIC CHEMISTRY

IF4.7

2023-07-319

PRE

Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer

NUCLEAR MEDICINE AND BIOLOGY

IF3

2023-07-017

PRE

Copper-Mediated Radiobromination of (Hetero)Aryl Boronic Pinacol Esters

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2023-02-065

PRE

A High Separation Factor for 165Er from Ho for Targeted Radionuclide Therapy

Ho中165Er的高分离因子用于靶向放射性核素治疗

MOLECULES

IF4.6

2021-12-118

OAAI

Alternating Current Electrolysis for Organic Electrosynthesis: Trifluoromethylation of (Hetero)arenes

ORGANIC LETTERS

IF5

2020-07-1388

PREAI

Lowering Interfacial Dissolved Gas Concentration for Highly Efficient Hydrazine Oxidation at Platinum by Fluorosurfactant Modulation

CHEMELECTROCHEM

IF3.5

2019-11-207

PREAI

The Role of Trichloroacetimidate To Enable Iridium-Catalyzed Regio-and Enantioselective Allylic Fluorination: A Combined Experimental and Computational Study

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2019-08-2231

PREAI

Iridium-Catalyzed Radiosynthesis of Branched Allylic [18F]Fluorides

ORGANIC LETTERS

IF5

2018-12-218

PREAI

Asymmetric Synthesis of Allylic Fluorides via Fluorination of Racemic Allylic Trichloroacetimidates Catalyzed by a Chiral Diene-Iridium Complex

手性二烯-铱配合物催化外消旋烯丙基三氯乙酰胺氟化不对称合成烯丙基氟化物

ACS CATALYSIS

IF13.1

2017-12-2934

PREAI

Jason C. Mixdorf

个人简介

教育背景

工作经历

荣誉奖项

研究方向